Prevalence of drug use before and during imprisonment in seven European countries (2014-2018).
Europe
criminal justice system
drugs
prevalence
prisons
substance use
survey
Journal
Journal of community psychology
ISSN: 1520-6629
Titre abrégé: J Community Psychol
Pays: United States
ID NLM: 0367033
Informations de publication
Date de publication:
12 May 2023
12 May 2023
Historique:
revised:
21
04
2023
received:
14
09
2022
accepted:
01
05
2023
pubmed:
12
5
2023
medline:
12
5
2023
entrez:
12
5
2023
Statut:
aheadofprint
Résumé
Substance use is a global phenomenon that is particularly affecting the prison population. This study aimed to describe the prevalence of drug use among people in prison before and during incarceration in seven European countries and to compare it with the prevalence in the general population. Individual data collection was carried out between 2014 and 2018 with a model European Questionnaire on Drug Use among people in prison. A total of 12,918 people living in prison filled in the survey. People in prison report higher level of drug use when compared with the general population and the use of drug inside prison exist, although at lower levels when compared with predetention. Prisons can represent a point of access to engage individuals who use drugs in interventions that address drug use and risk factors related to both drug use and imprisonment.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 The Authors. Journal of Community Psychology published by Wiley Periodicals LLC.
Références
Aebi, M. F., & Delgrande, N. (2018). Council of Europe Annual Penal Statistics SPACE I - Prison Populations Survey 2016 (p. 193). Council of Europe & University of Lausanne.
Aebi, M. F., & Tiago, M. M. (2019). SPACE I - 2018. Council of Europe.
Aebi, M., Tiago, M., & Burkhardt, C. (2015). SPACE I - Council of Europe Annual Penal Statistics: Prison populations. Survey 2014 March (Vol. 36, 97, pp. 52-53). Council of Europe.
Boys, A., Farrell, M., Bebbington, P., Brugha, T., Coid, J., Jenkins, R., Lewis, G., Marsden, J., Meltzer, H., Singleton, N., & Taylor, C. (2002). Drug use and initiation in prison: Results from a national prison survey in England and Wales. Addiction, 97(12), 1551-1560. https://doi.org/10.1046/j.1360-0443.2002.00229.x
Bukten, A., Lund, I. O., Kinner, S. A., Rognli, E. B., Havnes, I. A., Muller, A. E., & Stavseth, M. R. (2020). Factors associated with drug use in prison-Results from the Norwegian offender mental health and addiction (NorMA) study. Health & Justice, 8(1), 10. https://doi.org/10.1186/s40352-020-00112-8
Carpentier, C., Royuela, L., Montanari, L., & Davis, P. (2018). The global epidemiology of drug use in prison. In J. D. Kinner & S. J. Rich (Eds.), Drug use in prisoners (pp. 17-42). Oxford University Press.
Carpentier, C., Royuela, L., Noor, A., & Hedrich, D. (2012a). Ten years of monitoring illicit drug use in prison populations in Europe: Issues and challenges. Howard Journal of Criminal Justice, 51(1), 37-66. https://doi.org/10.1111/j.1468-2311.2011.00677.x
Comiskey, C., Bretteville-Jensen, A. L., Bergeron, H., Bühringer, G., Dargan, P., Davoli, M., Faggiano, F., Fischer, G., Rodríguez de Fonseca, F., Garretsen, H., Hickman, M., Korf, D. J., Krajewski, K., Paoli, L., & Spanagel, R. (2020). Better data, better policy and better lives: A call for improved drug monitoring and concerted responses. Addiction (Abingdon, England), 115, 199-200. https://doi.org/10.1111/add.14763
Council of the European Union. (2001). Council resolution on the implementation of the five key epidemiological indicators on drugs, developed by the European Monitoring Centre for drugs and drug addiction (EMCDDA). CORDROGUE, 67, 11-13.
Council of the European Union. (2006). Regulation (EC) No 1920/2006 of the European Parliament and of the Council of 12 December 2006 on the European Monitoring Centre for Drugs and Drug Addiction (recast). Official Journal of the European Union, 1920(787), 1-13.
Council of the European Union. (2012). EU drug strategy (2013-2020). Official Journal of the European Union, 1971(C402), 1-10.
Council of the European Union. (2013). EMCDDA contribution towards a methodological framework for monitoring drugs and prison in Europe.
Council of the European Union. (2017). EU action plan on drugs 2017-2020. Official Journal of the European Union, C215, 21.
Dolan, K., Wirtz, A. L., Moazen, B., Ndeffo-mbah, M., Galvani, A., Kinner, S. A., Courtney, R., McKee, M., Amon, J. J., Maher, L., Hellard, M., Beyrer, C., & Altice, F. L. (2016). Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. The Lancet, 388(10049), 1089-1102. https://doi.org/10.1016/S0140-6736(16)30466-4
EMCDDA. (2012). Prisons and drugs in Europe: The problem and responses, European monitoring centre for drugs and drug addiction (pp. 1-36). https://doi.org/10.2810/73390
EMCDDA. (2018a). European Drug Report 2018 - Trends and developments legal notice. https://doi.org/10.2810/88175
EMCDDA. (2018b). New psychoactive substances in prison, Early warning system. https://doi.org/10.2810/372415
Enkelmann, J., Gassowski, M., Nielsen, S., Wenz, B., Roß, S., Marcus, U., Bremer, V., & Zimmermann, R. (2020). High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011-2014: Missed opportunities for hepatitis C testing. Harm Reduction Journal, 17(1), 7. https://doi.org/10.1186/s12954-019-0338-y
European Monitoring Centre for Drugs and Drug Addiction. (2018). New psychoactive substances in prison. Publications Office of the European Union.
European Monitoring Centre for Drugs and Drug Addiction. (2022). Prison and drugs in Europe: Current and future challenges. Publications Office of the European Union, Luxembourg. https://www.emcdda.europa.eu/system/files/publications/13904/TDXD21001ENN.pdf
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2009). An overview of the general populations survey (GPS) key indicator.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2011). Drug policy profile, Portugal. https://doi.org/10.2810/41390
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2014). European questionnaire on drug use among prisoners (EQDP) (April).
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2018c). Cannabis legislation in Europe. Publications Office of the European Union. https://doi.org/10.2810/930744
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2021a). European questionnaire on drug use among people living in prison (EQDP). Long version (October).
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2021b). European questionnaire on drug use among people living in prison (EQDP). Methodological guidelines (October).
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2021c). European questionnaire on drug use among people living in prison (EQDP). Short version (October).
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2022). European Drug Report Trends and Developments.
Fazel, S., Yoon, I. A., & Hayes, A. J. (2017). Substance use disorders in prisoners: An updated systematic review and meta-regression analysis in recently incarcerated men and women. Addiction, 112(10), 1725-1739. https://doi.org/10.1111/add.13877
Fuentes, C. M. (2013). Nobody's child: The role of trauma and interpersonal violence in women's pathways to incarceration and resultant service needs. Medical Anthropology Quarterly, 28(1), 85-104. https://doi.org/10.1111/maq.12058
General Secretariat of the Council (Council of the European Union). (2021). EU drugs strategy 2021-2025 (December, pp. 1-18). https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:C:2021:102I:FULL&from=EN
Griffiths, P., Mounteney, J., Lopez, D., Zobel, F., & Götz, W. (2012). Addiction research centres and the nurturing of creativity. Monitoring the European drug situation: The ongoing challenge for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Addiction, 107(2), 254-258. https://doi.org/10.1111/j.1360-0443.2011.03369.x
Hartnoll, R. (2003). Drug epidemiology in the European institutions: Historical background and key indicators. Bulletin on Narcotics, 55(1-2), 53-71.
Kolind, T., & Bjønness, J. (2017). ‘The right way to be a woman’: Negotiating femininity in a prison-based drug treatment programme. Punishment & Society, 21(1), 107-124. https://doi.org/10.1177/1462474517749049
Ministero della Giustizia (Ministry of Justice). (2020). Detenuti italiani e stranieri presenti e capienze per istituto - aggiornamento al 31 gennaio 2020 (Italian and foreign inmates present and capacities by institution - update as of January 31, 2020). https://www.giustizia.it/giustizia/it/mg_1_14_1.page?contentId=SST245520&previsiousPage=mg_1_14
Montanari, L., Mravcik, V., Grohmannova, K., & Royuela, L. (2017). European Questionnaire on Drug Use among Prisoners (EQDP) (April, pp. 1-19). EMCDDA.
Mounteney, J., Griffiths, P., Sedefov, R., Noor, A., Vicente, J., & Simon, R. (2016). The drug situation in Europe: An overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015. Addiction, 111(1), 34-48. https://doi.org/10.1111/add.13056
Niveau, G., & Ritter, C. (2008). Route of administration of illicit drugs among remand prison entrants. European Addiction Research, 14(2), 92-98. https://doi.org/10.1159/000113723
Plugge, E., Yudkin, P., & Douglas, N. (2009). Changes in women's use of illicit drugs following imprisonment, Addiction (Vol. 104, 2, pp. 215-222). Wiley Online Library. https://doi.org/10.1111/j.1360-0443.2008.02419.x
Royuela, L., Montanari, L., Rosa, M., & Vicente, J. (2014). Drug use in prison: Assessment report. Reviewing tools for monitoring illicit drug use in prison populations in Europe (pp. 1-35). EMCDDA.
Sánchez, F. C., Fearn, N., Vaughn, M. G., Caravaca, F., Fearn, N., & Vaughn, M. G. (2017). Prevalence and correlates of in-prison substance use among incarcerated women in Spain. Journal of Ethnicity in Substance Abuse, 17(3), 356-374. https://doi.org/10.1080/15332640.2016.1255579
Stöver, H., Teltzrow, R., Boci, A., Dedajic, D., Otiashvili, D., Ismajli, R., Condrat, I., Colakovic, J., Zegura, T., Milkov, D., Vucicevic, Z., Sarang, A., Dvoriak, S., Mendelevich, V., Ignjatova, L., & Kiriazova, T. (2017). Drug-treatment systems in prisons in Eastern and South-East Europe. Council of Europe. https://rm.coe.int/drug-treatment-systems-in-prisons-in-eastern-and-south-east-europe/168075b999
Teltzrow, R., & Stöver, H. (2017). Drug treatment systems in prison in Eastern and South-East Europe. Council of Europe.
Treloar, C., McCredie, L., & Lloyd, A. R. (2016). The prison economy of needles and syringes: What opportunities exist for blood borne virus risk reduction when prices are so high. PLoS ONE, 11(9), e0162399. https://doi.org/10.1371/journal.pone.0162399
UNODC - United Nations Office on Drugs and Crime. (2018). World drug report: Booklet 5-Women and drugs, World drug report 2018.
van de Baan, F. C., Montanari, L., Royuela, L., & Lemmens, P. H. H. M. (2022). Prevalence of illicit drug use before imprisonment in Europe: Results from a comprehensive literature review. Drugs: Education, Prevention and Policy, 29(1), 1-12. https://doi.org/10.1080/09687637.2021.1879022
Van Den Bergh, B., Gatherer, A., Fraser, A., & Moller, L. (2011). Imprisonment and women's health: Concerns about gender sensitivity, human rights and public health. Bulletin of the World Health Organization, 89(July), 689-694. https://doi.org/10.2471/BLT.10.082842
World Health Organisation. (2019). 6th Prison Health Conference Prison health systems: The interface with wider national health systems (March, pp. 1-37).